Vitality Re VII Ltd Series 2016-1

Share

Vitality Re VII ILS helps Aetna reduce required capital & gain reinsurance

Health insurance company Aetna has hailed the completion of its latest ILS transaction, Vitality Re VII Ltd. (Series 2016-1), which it says help it to "reduce its required capital" while gaining a $200m source of collateralized excess of loss reinsurance.The Vitality Re II 2016-1 health insurance loss ratio linked ILS, read the full article →

Aetna’s Vitality Re VII medical benefit cat bond prices at top-end

Health insurance firm Aetna's $200m Vitality Re VII Ltd. (Series 2016-1) health insurance medical benefit ratio catastrophe bond deal has now been priced, with the coupon settling at the upper end of the initial guidance range.When this ILS deal launched almost a fortnight ago, it saw Aetna seeking to gain read the full article →

Aetna back with $200m Vitality Re VII health insurance linked ILS

Health insurance firm Aetna is returning to the capital markets in search of another $200 million or more of fully-collateralised reinsurance protection for losses under its health insurance medical benefit ratio, through a Vitality Re VII Ltd. (Series 2016-1) ILS issuance.Aetna has been using the insurance-linked securities (ILS) market as read the full article →